Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
M/I Homes
MHO
$3.87B
| $1.02M | ﹤0.01% |
42,669
-5,759
| -12% | -$149K |
|
3552
PUT
MPLX
MPLX
$59.9B
| $1.02M | ﹤0.01% |
29,400
+19,600
| +200% | +$702K |
|
3553
CALL
SolarEdge
SEDG
$2B
| $1.02M | ﹤0.01% |
27,000
-39,300
| -59% | -$1.89M |
|
3554
Shenandoah Telecom
SHEN
$739M
| $1.02M | ﹤0.01% |
26,222
+21,648
| +473% | +$771K |
|
3555
Community Health Systems
CYH
$423M
| $1.01M | ﹤0.01% |
293,488
+227,215
| +343% | +$739K |
|
3556
CALL
Owens Corning
OC
$12.2B
| $1.01M | ﹤0.01% |
18,700
+18,500
| +9,250% | +$1.11M |
|
3557
NeoGenomics
NEO
$2.06B
| $1.01M | ﹤0.01% |
66,012
+1,389
| +2% | +$19.2K |
|
3558
PUT
Nasdaq
NDAQ
$54.2B
| $1.01M | ﹤0.01% |
35,400
+11,400
| +48% | +$351K |
|
3559
WSFS Financial
WSFS
$4.18B
| $1.01M | ﹤0.01% |
21,464
+17,649
| +463% | +$908K |
|
3560
Invesco DB US Dollar Index Bullish Fund
UUP
$413M
| $1.01M | ﹤0.01% |
40,001
+39,998
| +1,333,267% | +$1.01M |
|
|
INXN
3561
DELISTED
Interxion Holding N.V.
INXN
| $1.01M | ﹤0.01% |
15,006
-9,958
| -40% | -$646K |
|
|
EXTN
3562
DELISTED
Exterran Corporation
EXTN
| $1.01M | ﹤0.01% |
38,042
+20,662
| +119% | +$555K |
|
|
AEGN
3563
DELISTED
Aegion Corp
AEGN
| $1.01M | ﹤0.01% |
39,761
+24,084
| +154% | +$601K |
|
|
ONCE
3564
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.01M | ﹤0.01% |
18,494
+12,982
| +236% | +$888K |
|
3565
iShares MSCI Canada ETF
EWC
$6.55B
| $1.01M | ﹤0.01% |
34,962
+6,388
| +22% | +$184K |
|
3566
Gray Television
GTN
$528M
| $1.01M | ﹤0.01% |
57,464
+47,614
| +483% | +$779K |
|
3567
PUT
Cencora
COR
$59.2B
| $1M | ﹤0.01% |
10,900
-13,900
| -56% | -$1.2M |
|
|
USG
3568
PUT
DELISTED
Usg
USG
| $1M | ﹤0.01% |
23,200
| – | – |
|
|
LL
3569
PUT
DELISTED
LL Flooring Holdings, Inc.
LL
| $1M | ﹤0.01% |
64,800
+35,400
| +120% | +$714K |
|
|
CY
3570
CALL
DELISTED
Cypress Semiconductor
CY
| $1M | ﹤0.01% |
69,100
+12,400
| +22% | +$204K |
|
3571
Barclays
BCS
$94.6B
| $999K | ﹤0.01% |
116,801
| – | – |
|
|
HCR
3572
CALL
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $998K | ﹤0.01% |
92,400
-6,900
| -7% | -$86.6K |
|
3573
CALL
AGNC Investment
AGNC
$13B
| $997K | ﹤0.01% |
53,500
-8,600
| -14% | -$164K |
|
3574
CALL
Canadian Solar
CSIQ
$1.04B
| $996K | ﹤0.01% |
68,700
+1,600
| +2% | +$22K |
|
3575
PUT
Equinix
EQIX
$108B
| $996K | ﹤0.01% |
2,300
+1,200
| +109% | +$525K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.